Ultrasound meets nanomedicine: towards disease treatment and medical imaging DOI
Xiaochun Li, Yanting Liu,

Xuewan Wu

et al.

Microchimica Acta, Journal Year: 2025, Volume and Issue: 192(4)

Published: March 7, 2025

Language: Английский

A Sustainable ROS Cycle Generator (Srcg) for Tumor Chemodynamic Therapy DOI
Yuling Zhang,

Yingying Pan,

Yaguang Ren

et al.

Published: Jan. 1, 2025

Language: Английский

Citations

0
Photothermal Antibacterial Therapy of Near-Infrared II Region Laser Mediated by Gold Hollow Nanorod DOI
Yan Wang,

S. S. Pan,

Wenqiong Zhang

et al.

Langmuir, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 24, 2025

The current traditional treatment for bacterial infections is to treat them with antibiotics, and the misuse of antibiotics can lead an increase in resistance. In contrast, development new much slower than speed adaptation drug-resistant bacteria, making it necessary develop a drug that does not rely on antibiotics. Therefore, based advantages photothermal therapy, NIR II-responsive gold hollow nanorods (GHNRs) were developed overcome limitation resistance conventional therapy. GHNRs quickly respond 980 nm laser high conversion efficiency 41.78%. temperature produced by effectively kill Staphylococcus aureus Escherichia coli, providing strategy clinical infectious diseases without antibiotic dependence.

Language: Английский

Citations

0
Nanomaterials for liver cancer targeting: research progress and future prospects DOI Creative Commons
Jiahong Xu,

Yefu Liu

Frontiers in Immunology, Journal Year: 2025, Volume and Issue: 16

Published: Feb. 28, 2025

The incidence and mortality rates of liver cancer in China remain elevated. Although early-stage is amenable to surgical resection, a significant proportion patients are diagnosed at advanced stages. Currently, addition resection for hepatocellular carcinoma, the primary treatment modalities predominantly include chemotherapy. widespread use chemotherapy, which non-selectively targets both malignant healthy cells, often results substantial immunosuppression. Simultaneously, accumulation chemotherapeutic agents can readily induce drug resistance upon reaching physiological threshold, thereby diminishing efficacy these treatments. Besides there exist targeted therapy, immunotherapy other therapeutic approaches. Nevertheless, development remains an inevitable challenge. To address challenges, we turn nanomedicine, emerging widely utilized discipline that significantly influences medical imaging, antimicrobial strategies, delivery systems, related areas. Stable safe nanomaterials serve as effective carriers delivering anticancer drugs. They enhance precision targeting, improve bioavailability, minimize damage cells. This review focuses on common nanomaterial used carcinoma (HCC) over past five years. following summary three drugs: Sorafenib, Gefitinib, lenvatinib. Each employs distinct result varying levels release rates, efficacy.

Language: Английский

Citations

0
NIR-II photo- and sono-responsive hyaluronic acid-capped nanozymes for glioblastoma-targeting theranostics DOI

Huanran Qu,

Yuanyuan Zhang, Minghao Chen

et al.

International Journal of Biological Macromolecules, Journal Year: 2025, Volume and Issue: 306, P. 141737 - 141737

Published: March 4, 2025

Language: Английский

Citations

0
Ultrasound meets nanomedicine: towards disease treatment and medical imaging DOI
Xiaochun Li, Yanting Liu,

Xuewan Wu

et al.

Microchimica Acta, Journal Year: 2025, Volume and Issue: 192(4)

Published: March 7, 2025

Language: Английский

Citations

0